tirzepatide semaglutide user reviews comparison vs Tirzepatide: Which GLP-1 Wins for Weight Loss? Comparative safety and side effects

Cardiovascular benefits The SELECT trial a landmark cardiovascular outcomes study involving over 17,000 participants showed that semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in people with obesity who did not have diabetes

Even women with regular periods may not know that theyre pregnant until six weeks gestation or beyond

The four STEP studies involved 4,500 individuals from around the world that were either affected by obesity or classified as overweight with co-existing medical conditions resulting from their excess weight

Reduced cardiovascular risk factors: Being obese often means you have a higher chance of getting heart problems

Thyroxine therapy may be decreased to maintain a low but not suppressed serum TSH concentration (0.1-0.4 U/ml)

They work best when paired with healthy habits like balanced eating, regular movement, and ongoing checkins with a healthcare provider to make sure progress stays safe and sustainable